Cargando…

Editorial: Immunosenescence and multiple sclerosis: Prognostic and therapeutic implications

Detalles Bibliográficos
Autores principales:	Zanghì, Aurora, Avolio, Carlo, Hartung, Hans-Peter, D'Amico, Emanuele
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9481414/ https://www.ncbi.nlm.nih.gov/pubmed/36119682 http://dx.doi.org/10.3389/fneur.2022.996342

Ejemplares similares

Ofatumumab and Early Immunological Cells Subset Characterization in Naïve Relapsing Multiple Sclerosis Patients: A Real-World Study
por: D’Amico, Emanuele, et al.
Publicado: (2023)

Injectable versus oral first-line multiple sclerosis therapies: knows and unknowns from observational studies
por: D'Amico, Emanuele, et al.
Publicado: (2021)

MiRNA 106a-5p in cerebrospinal fluid as signature of early relapsing remitting multiple sclerosis: a cross sectional study
por: Zanghì, Aurora, et al.
Publicado: (2023)

Pregnancy and the Postpartum Period in Women With Relapsing-Remitting Multiple Sclerosis Treated With Old and New Disease-Modifying Treatments: A Real-World Multicenter Experience
por: Zanghì, Aurora, et al.
Publicado: (2020)

Gonadal Steroids and Sperm Quality in a Cohort of Relapsing Remitting Multiple Sclerosis: A Case-Control Study
por: D'Amico, Emanuele, et al.
Publicado: (2020)

Cancer Risk and Multiple Sclerosis: Evidence From a Large Italian Cohort
por: D'Amico, Emanuele, et al.
Publicado: (2019)

First‐line therapies in late‐onset multiple sclerosis: An Italian registry study
por: Zanghì, Aurora, et al.
Publicado: (2021)

A Personalized Approach in Progressive Multiple Sclerosis: The Current Status of Disease Modifying Therapies (DMTs) and Future Perspectives
por: D’Amico, Emanuele, et al.
Publicado: (2016)

Stopping Interferon Beta 1b Does Not Influence the Risk of Disability Accrual in Non-Active SPMS: Results from an Italian Real-World Study
por: Zanghì, Aurora, et al.
Publicado: (2022)

Exploring polypharmacy phenomenon in newly diagnosed relapsing–remitting multiple sclerosis: a cohort ambispective single-centre study
por: Zanghì, Aurora, et al.
Publicado: (2021)

Personality Traits and Fatigue in Multiple Sclerosis: A Narrative Review
por: Ciancio, Alessia, et al.
Publicado: (2023)

Immunosenescence and multiple sclerosis: inflammaging for prognosis and therapeutic consideration
por: Thakolwiboon, Smathorn, et al.
Publicado: (2023)

The Neutrophil-to-Lymphocyte Ratio is Related to Disease Activity in Relapsing Remitting Multiple Sclerosis
por: D’Amico, Emanuele, et al.
Publicado: (2019)

Mental health status of relapsing-remitting multiple sclerosis Italian patients returning to work soon after the easing of lockdown during COVID-19 pandemic: A monocentric experience
por: Zanghì, Aurora, et al.
Publicado: (2020)

Role of Gut Microbiota in Multiple Sclerosis and Potential Therapeutic Implications
por: Wang, Xu, et al.
Publicado: (2022)

Editorial: Cognition in Multiple Sclerosis
por: Cortese, Rosa, et al.
Publicado: (2021)

Editorial: Preventing multiple sclerosis
por: Dobson, Ruth, et al.
Publicado: (2022)

Autoimmune liver disease and multiple sclerosis: state of the art and future perspectives
por: Villani, Rosanna, et al.
Publicado: (2023)

Theoretical and Therapeutic Implications of the Spasticity-Plus Syndrome Model in Multiple Sclerosis
por: Bruno, Antonio, et al.
Publicado: (2022)

New Insights Into Immune Cell-Derived Extracellular Vesicles in Multiple Sclerosis
por: Blonda, Maria, et al.
Publicado: (2018)

Editorial: Corticospinal Excitability in Patients With Multiple Sclerosis
por: Chalah, Moussa A., et al.
Publicado: (2021)

Editorial: Disease modifying therapies in multiple sclerosis
por: Bonavita, Simona, et al.
Publicado: (2022)

Editorial: Insights in multiple sclerosis and neuroimmunology: 2021
por: Weissert, Robert
Publicado: (2023)

Therapeutic Advances in Multiple Sclerosis
por: Yang, Jennifer H., et al.
Publicado: (2022)

Metabolic Abnormalities, Dietary Risk Factors and Nutritional Management in Amyotrophic Lateral Sclerosis
por: D’Amico, Emanuele, et al.
Publicado: (2021)

Immunological Subsets Characterization in Newly Diagnosed Relapsing–Remitting Multiple Sclerosis
por: D’Amico, Emanuele, et al.
Publicado: (2022)

Editorial: Pain in multiple sclerosis and experimental autoimmune encephalomyelitis
por: Lovett-Racke, Amy, et al.
Publicado: (2022)

Editorial: Fatigue in multiple sclerosis—A current perspective
por: Pokryszko-Dragan, Anna, et al.
Publicado: (2023)

Editorial: CNS autoimmune disorders and COVID-19
por: Mirmosayyeb, Omid, et al.
Publicado: (2023)

Editorial: Immunosenescence after sepsis
por: Lu, Xuan, et al.
Publicado: (2023)

Editorial: Immunosenescence in the cancer microenvironment
por: Puca, Annibale Alessandro, et al.
Publicado: (2023)

Multiple Sclerosis as a Syndrome—Implications for Future Management
por: Dwyer, Christopher M., et al.
Publicado: (2020)

Editorial: Multiple Sclerosis and Neuroimmunology—Case Report Collection, Volume I
por: Weissert, Robert
Publicado: (2022)

Case Report: A Case of Severe Clinical Deterioration in a Patient With Multiple Sclerosis
por: Breitkopf, Katharina, et al.
Publicado: (2020)

An Overview of Therapeutic Options in Relapsing-remitting Multiple Sclerosis
por: Saleem, Sidra, et al.
Publicado: (2019)

Editorial: Effects of epilepsy on memory—Therapeutic implications, biomarkers, and comorbidities
por: Höller, Yvonne, et al.
Publicado: (2023)

Editorial: Women in multiple sclerosis and other demyelinating disorders: A global perspective
por: Ciampi, Ethel, et al.
Publicado: (2023)

Neurological update: treatment escalation in multiple sclerosis patients refractory to fingolimod—potentials and risks of subsequent highly active agents
por: Korsen, Melanie, et al.
Publicado: (2022)

Usability of an Educational Intervention to Overcome Therapeutic Inertia in Multiple Sclerosis Care
por: Saposnik, Gustavo, et al.
Publicado: (2018)

Therapeutic Inertia in Multiple Sclerosis Care: A Study of Canadian Neurologists
por: Saposnik, Gustavo, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_5chdf2rqdjp6pltdi8q2tkrne6